PENK Methylation Test for Detecting Bladder Cancer

Exclusion Criteria

• •Individuals who do not agree to voluntarily sign an informed consent prior to the initiation of screening
• •Subjects aged \<40 years
• •Subjects with a history of bladder cancer and upper tract urothelial cancer
• •Female who are currently menstruating or who have had their last menstrual period within the last 3 days
• •Subjects who have undergone invasive procedures in the urinary tract system within the last 3 months
• •Subjects with suspected upper urothelial cancer lesions on ultrasound or CT scan
• •Subjects who have previously received pelvic radiation therapy
• •Subjects who have been diagnosed with other cancers and have received or are currently receiving chemotherapy or immunotherapy within 6 months
• •Subjects who require treatment for an active urinary tract infection or vaginitis
• •Subjects undergoing prostate cancer treatment or requiring a prostate biopsy
• •Subject has any condition which, in the opinion of the investigator should preclude participation in the study